AMBER STEINMETZ: Open Payments
NPI 1780312470 · PORT HURON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,707 in 91 payments from 17 companies in 2025. Trend: 2023 $33 · 2024 $586 · 2025 $1,707
Food & beverage: $1,658Education: $49
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $480 |
| HARMONY BIOSCIENCES LLC | 14 | $317 |
| ABBVIE INC. | 30 | $287 |
| Corcept Therapeutics | 5 | $142 |
| Alkermes, Inc. | 4 | $94 |
| Axsome Therapeutics, Inc. | 3 | $66 |
| Novo Nordisk Inc | 2 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Indivior Inc. | 1 | $41 |
Products named: WAKIX, VRAYLAR, FARXIGA, BREZTRI, Korlym, ARISTADA, AIRSUPRA, Auvelity.
Industry payments across MI — which companies pay providers there.
